| Entry |
|
|---|
| Name |
Elastase ES;
Elaszym (TN) |
|---|
| Class |
Hypolipidemic agent
DG01946 Hypolipidemic agent
|
|---|
| Remark |
| Therapeutic category: | 2189 |
|
|---|
| Efficacy |
Antihyperlipidemic, Cholesterol catabolism enhancer, Lipoprotein lipase (LPL) activator, Lecithin-cholesterol acyltransferase (LCAT) activator |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
218 Hyperlipidemia agents
2189 Others
D04268 Elastase ES
Drug groups [BR:br08330]
Hypolipidemic agent
DG01946 Hypolipidemic agent
D04268 Elastase ES
Drug classes [BR:br08332]
Cardiovascular agent
DG01946 Hypolipidemic agent
D04268 Elastase ES
Target-based classification of drugs [BR:br08310]
Enzymes
Transferases (EC2)
Acyltransferases
LCAT
D04268 Elastase ES <JP>
Hydrolases (EC3)
Carboxylic-ester hydrolases
LPL
D04268 Elastase ES <JP>
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
